GLP-1 - HealthQuill

Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic patients during an end-stage trial, better than rival Eli Lilly’s drug.

Novo Nordisk’s test drug outperforms rival Lilly’s in diabetic patients

HQ Team September 21, 2026: Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic.

by HealthQuill
September 21, 2026
0 Comments

Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants, showed patients lost about 23% of their body weight compared to a dummy group’s 2-3%.

Health

GLP-1 drugs may stop early-stage cancers from spreading

HQ Team July 28, 2026: People taking GLP-1 drugs (glucagon-like peptide-1 receptor agonists, the same class as Ozempic and Wegovy) for diabetes alongside.

by HealthQuill
July 28, 2026
0 Comments

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.

Drugs

Health benefits hype drive FDA to review 7 peptides and their sale

HQ Team July 23, 2026: Peptides, the short chains of amino acids that serve as the building blocks of proteins, are generating significant.

by HealthQuill
July 23, 2026
0 Comments

Obesity is a health risk that needs to be tackled worldwide

Drugs Health

Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results

HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their.

by HealthQuill
June 17, 2026
0 Comments

Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.

Health Opinion

Are GLP-1 drugs fuelling an eating disorder crisis globally?

Swati Sri April 27, 2026: Glucon-like Peptides-1 (GLP-1) agonists stabilize blood glucose by stimulating insulin secretion and suppressing glucagon production in the body..

by HealthQuill
April 27, 2026
0 Comments

Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing average blood sugar levels by up to 2.16% in diabetic patients and trimmed weight by almost 10%, according to a statement.

Drugs Health Pharma

Novo, United’s trial drug cuts sugar levels by 2.16%, weight loss of 9.8%

HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing.

by HealthQuill
March 25, 2026
0 Comments

Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat Alzheimer’s disease, diabetes and obesity, according to a company statement.

Drugs Pharma

Eli Lilly sounds alarm on counterfeit weight-loss drugs mixed with vitamin B12

HQ Staff Writer March 13, 2026: Eli Lily, the pharmaceutical giant, has warned that compounded versions of its blockbuster weight-loss drug tirzepatide, when.